Using Comparative Effectiveness Data Based on Non-Randomized Study Designs to Support Regulatory, Reimbursement Decision-Making
Sreeram Ramagopalan, PhDStudy provides evidence to support the potential role of real-world data in consideration of technologies where only single-arm trial data exists. Read more
In Measuring Outcomes, a Longer-Term View May be Needed
Mark Hennon, MD+more
When publicly reported patient outcomes emerge, the data available to patients should paint the most complete picture possible. Read more
Alternative Dosing Strategies for Immune Checkpoint Inhibitors
Michiel Zietse, MSc+more
Combining fixed- and weight-based dosing approaches may reduce costs without compromising efficacy. Read more
Panel Explores Emerging Treatments and Sequencing Strategies for Patients with Advanced NSCLCs Driven by Rare Oncogenes
Beth Fand IncollingoDuring the 2022 European Lung Cancer Congress, experts reviewed evidence on drugs targeting MET exon 14 skipping mutations and RET, HER2, and BRAF alterations. Read more
Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System
Beth Fand IncollingoA presentation at the 2022 European Lung Cancer Congress convinced attendees that the current system for staging lung cancer needs refinement. Read more
A real-world look at diagnostic-therapeutic pathways explores how they may help provide optimal, innovative care without ballooning costs. Read more
Small, High PLCG2-Expressing Intratumoral Cells May Drive Metastasis
Alvaro Quintanal-Villalonga, PhD+more
In the search to understand the mechanisms of metastasis, researchers have expanded the spectrum of SCLC clinical specimens amenable for single-cell resolution analysis. Read more
COAST Data Support Further Research of Immunotherapy Combinations
Mariona Riudavets, MD, PhD+more
Trial is the first to show improved efficacy and a manageable safety profile after cCRT in unresectable locally advanced stage III NSCLC regardless of PD-L1 status. Read more
TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan
Joy CurzioDr. Benjamin C. Creelan shares his passion for cell therapy research and insights into current data. Read more
Early Palliative Care: A European Perspective
Florian Scotté, MD, PhDThe benefits of early palliative care have been proven. Could negative connotations of palliative care be impeding its adoption? Read more